NEVOLV Trademark

Trademark Overview

On Thursday, December 22, 2011, a trademark application was filed for NEVOLV with the United States Patent and Trademark Office. The USPTO has given the NEVOLV trademark a serial number of 85501952. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 3, 2022. This trademark is owned by Glaxo Group Limited. The NEVOLV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nevolv

General Information

Serial Number85501952
Word MarkNEVOLV
Filing DateThursday, December 22, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 3, 2022
Registration Number4857439
Registration DateTuesday, November 24, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "NEVOLV" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Friday, June 3, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, November 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 24, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, July 17, 2015NOTICE OF ALLOWANCE CANCELLED
Tuesday, July 28, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014SOU EXTENSION 5 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 5 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Friday, June 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2014SOU EXTENSION 4 GRANTED
Monday, June 23, 2014SOU EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Friday, January 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2014SOU EXTENSION 3 GRANTED
Thursday, January 9, 2014SOU EXTENSION 3 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013SOU EXTENSION 2 GRANTED
Friday, July 5, 2013SOU EXTENSION 2 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2012SOU EXTENSION 1 GRANTED
Friday, December 14, 2012SOU EXTENSION 1 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Tuesday, July 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 17, 2012ASSIGNED TO LIE
Tuesday, March 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 20, 2012ASSIGNED TO EXAMINER
Wednesday, January 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 26, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

nevolv pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological